|Mr. Robert J. Palmisano||Pres, CEO & Exec. Director||2.24M||N/A||1945|
|Mr. Lance A. Berry||Exec. VP, CFO & COO||817.73k||N/A||1972|
|Mr. Andrew C. Morton||Sr. VP & Chief HR Officer||973.48k||N/A||1966|
|Mr. Kevin D. Cordell||Exec. VP & Chief Global Commercial Officer||825.09k||N/A||1966|
|Mr. Peter S. Cooke||Pres of emerging markets, Australia & Japan||2.18M||195.78k||1965|
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company primarily offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.
Wright Medical Group N.V.’s ISS Governance QualityScore as of July 29, 2019 is 4. The pillar scores are Audit: 3; Board: 2; Shareholder Rights: 2; Compensation: 8.